Anixa Biosciences (ANIX) Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial Jun 23, 2025 08:02AM
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial Jun 23, 2025 08:00AM
Anixa Biosciences to Host an Investor Webcast on June 26, 2025 Jun 20, 2025 07:30AM
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage Jun 10, 2025 07:00AM
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 Jun 9, 2025 08:00AM
View Older Stories

Jun 3, 2025 07:25AM Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview
Jun 2, 2025 07:00AM Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
May 19, 2025 08:00AM Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
May 12, 2025 08:00AM Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 30, 2025 08:00AM Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Apr 14, 2025 08:00AM Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Apr 9, 2025 08:03AM Anixa Biosciences (ANIX) Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Apr 9, 2025 08:00AM Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Apr 1, 2025 08:00AM Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Mar 25, 2025 08:00AM Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
Mar 24, 2025 08:04AM Anixa Biosciences (ANIX) Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
Mar 24, 2025 08:00AM Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
Mar 17, 2025 08:00AM Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
Mar 10, 2025 08:30AM Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Mar 3, 2025 08:00AM Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
Feb 26, 2025 08:00AM Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
Feb 25, 2025 07:30AM Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
Feb 24, 2025 08:00AM Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
Feb 18, 2025 08:07AM Anixa Biosciences (ANIX) Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Feb 18, 2025 08:00AM Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
Feb 14, 2025 07:00AM Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
Feb 11, 2025 08:30AM Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
Feb 4, 2025 08:30AM Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
Jan 21, 2025 08:33AM Anixa Biosciences (ANIX) CEO Provides Letter to Shareholders
Jan 21, 2025 08:30AM Anixa Biosciences CEO Provides Letter to Shareholders
Dec 4, 2024 08:30AM Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Nov 22, 2024 08:16AM Anixa Biosciences (ANIX) Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Nov 22, 2024 08:15AM Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Nov 18, 2024 08:20AM Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Nov 8, 2024 01:17PM Anixa Biosciences (ANIX) and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine
Nov 8, 2024 01:17PM Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Nov 6, 2024 08:30AM Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 31, 2024 08:15AM Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
Oct 28, 2024 08:30AM Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Oct 15, 2024 09:00AM Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
Oct 7, 2024 08:30AM Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development
Sep 30, 2024 08:31AM Anixa Biosciences (ANIX) Submits Protocol Amendment for CAR-T Trial
Sep 30, 2024 08:30AM Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
Sep 24, 2024 08:31AM Anixa Biosciences (ANIX) Unveils Phase 2 Study Plan for Breast Cancer Vaccine
Sep 24, 2024 08:30AM Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
Sep 18, 2024 08:30AM Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
Sep 3, 2024 08:30AM Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
Aug 26, 2024 08:30AM Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Jul 29, 2024 08:45AM Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Jul 23, 2024 08:17AM Anixa Biosciences (ANIX) Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Jul 23, 2024 08:15AM Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Jul 17, 2024 08:01AM Anixa Biosciences (ANIX) Announces Japanese Patent on Breast Cancer Vaccine Technology
Jul 17, 2024 08:00AM Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Jul 15, 2024 08:30AM Anixa Biosciences (ANIX) Announces $5 Million Share Repurchase Program
Jul 15, 2024 08:30AM Anixa Biosciences Announces $5 Million Share Repurchase Program
View Older Stories